In previous studies, Palmowski et al. successfully demonstrated therapeutic effects of a matrix metalloproteinase inhibitor at the molecular level on squamous cell carcinoma xenografts in mice using VEGFR-2-targeted microbubbles [10]. Here, KDR is linked to squamous cell carcinoma.